SCHEMBL27362636

SCHEMBL27362636

CNC(=O)C(CCC=O)Nc1ccc(C(C)(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ XBP1 P17861 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ KIF11 P52732 1/20 0.37
▸ NR1H4 Q96RI1 3/20 0.37
▸ EPHX2 P34913 2/20 0.37
▸ TRPV1 Q8NER1 4/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ PDK1 Q15118 1/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ PDK3 Q15120 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27368338 0.84 POLB (0.41) RAB9ANPC1MAPTMMP1MMP3
SCHEMBL27368112 0.79 PDK1 (0.36) SMN1; SMN2MAPK1HTTTRPV1PDK1
SCHEMBL23551763 0.74 NAMPT (0.40) —
SCHEMBL24491308 0.73 KDM1A (0.42) HDAC3HDAC11HDAC8HDAC6HDAC1
SCHEMBL25561171 0.70 HPGD (0.48) RAB9ANPC1SMN1; SMN2MEN1HTT
SCHEMBL23551340 0.70 JAK2 (0.43) NPC1
SCHEMBL25813333 0.69 ADAMTS5 (0.38) MAPT
SCHEMBL25557198 0.69 BMP1 (0.31) —
SCHEMBL29311609 0.68 CHRNB2 (0.38) SMN1; SMN2
SCHEMBL13284747 0.67 NPC1 (0.42) RAB9ANPC1SMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026083-A1 TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY RIBON THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback